D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Neurocrine Biosciences
NBIX
$17.7B
| $12.7M | 0.02% |
146,834
+17,523
| +14% | +$1.71M |
|
827
PUT
BP
BP
$113B
| $12.7M | 0.02% |
520,600
+257,400
| +98% | +$8.32M |
|
828
PUT
Teva Pharmaceuticals
TEVA
$35.9B
| $12.7M | 0.02% |
1,411,800
-1,416,100
| -50% | -$14.5M |
|
829
Occidental Petroleum
OXY
$57B
| $12.6M | 0.02% |
1,091,800
-118,819
| -10% | -$3.9M |
|
|
ABMD
830
PUT
DELISTED
Abiomed Inc
ABMD
| $12.6M | 0.02% |
87,100
-15,500
| -15% | -$2.57M |
|
831
CALL
Beyond Meat
BYND
$288M
| $12.6M | 0.02% |
189,300
-12,000
| -6% | -$1.16M |
|
832
CALL
Tyler Technologies
TYL
$12.2B
| $12.6M | 0.02% |
42,500
+6,900
| +19% | +$2.14M |
|
833
Alkermes
ALKS
$8.82B
| $12.6M | 0.02% |
872,492
-186,446
| -18% | -$3.33M |
|
834
CALL
Home Depot
HD
$332B
| $12.6M | 0.02% |
67,300
-158,200
| -70% | -$34.7M |
|
835
Fox Class B
FOX
$20.7B
| $12.5M | 0.02% |
547,914
-74,731
| -12% | -$2.42M |
|
836
Unisys
UIS
$227M
| $12.5M | 0.02% |
1,013,811
+396,564
| +64% | +$5.07M |
|
837
Expeditors International
EXPD
$22.9B
| $12.5M | 0.02% |
187,360
-179,340
| -49% | -$12.8M |
|
|
MXIM
838
DELISTED
Maxim Integrated Products
MXIM
| $12.4M | 0.02% |
254,350
-255,060
| -50% | -$14.6M |
|
839
PUT
DexCom
DXCM
$27.6B
| $12.4M | 0.02% |
183,600
+163,600
| +818% | +$10.2M |
|
840
AutoNation
AN
$6.97B
| $12.3M | 0.02% |
439,448
+306,889
| +232% | +$12.7M |
|
841
CALL
Broadcom
AVGO
$1.82T
| $12.3M | 0.02% |
520,000
-620,000
| -54% | -$17.5M |
|
842
Euronet Worldwide
EEFT
$3.02B
| $12.3M | 0.02% |
143,361
+140,400
| +4,742% | +$18.6M |
|
843
PUT
Universal Display
OLED
$3.71B
| $12.3M | 0.02% |
93,100
-74,000
| -44% | -$12.7M |
|
|
MIME
844
DELISTED
Mimecast Limited
MIME
| $12.3M | 0.02% |
347,267
-294,249
| -46% | -$12.7M |
|
845
Frontline
FRO
$8.75B
| $12.2M | 0.02% |
1,269,447
+1,051,705
| +483% | +$9.8M |
|
846
Elastic
ESTC
$6.1B
| $12.2M | 0.02% |
218,322
-126,925
| -37% | -$8.2M |
|
847
SAP
SAP
$187B
| $12.1M | 0.02% |
109,917
+102,122
| +1,310% | +$12.9M |
|
848
GoPro
GPRO
$116M
| $12.1M | 0.02% |
4,611,315
+1,248,836
| +37% | +$4.64M |
|
849
Ligand Pharmaceuticals
LGND
$6.02B
| $12.1M | 0.02% |
265,787
+143,045
| +117% | +$8.11M |
|
|
850
PUT
Tyler Technologies
TYL
$12.2B
| $12M | 0.02% |
40,600
+11,200
| +38% | +$3.47M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.